Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-151393 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 10, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
15,264
Total Value
$950,407.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Common Stock | โ | Apr 9, 2026 | Exercise/Conversion | 2,500 | $21.05 | $52,625.00 | 61,806 | Direct | โ | View Details | |
Chief Business Officer | Common Stock | โ | Apr 9, 2026 | Sale | 3,094 | $86.62 | $267,996.09 | 58,712 | Direct | โ | View Details | |
Chief Business Officer | Common Stock | โ | Apr 9, 2026 | Sale | 2,670 | $87.11 | $232,586.10 | 56,042 | Direct | โ | View Details | |
Chief Business Officer | Common Stock | โ | Apr 9, 2026 | Sale | 2,500 | $89.00 | $222,500.00 | 53,542 | Direct | โ | View Details | |
Chief Business Officer | Common Stock | โ | Apr 10, 2026 | Sale | 2,000 | $87.35 | $174,700.00 | 51,542 | Direct | โ | View Details | |
Chief Business Officer | Stock Option (Right to Buy) | Derivative | Apr 9, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 97,500 | Direct | โ | View Details |